Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1269)
•••
Post by GrahamBon Nov 17, 2024 6:01am
69 Views
Post# 36316929

Deja Vu

Deja VuHere is a post I made almost 3 years ago- has anything changed?
Interesting how the story remains the same , it seems the company can't get any traction and is stuck in neutral
Yawn.



Bullboard Posts
Next >>
User Avatar Image
(1187)
•••
Post by GrahamBon Feb 28, 2022 9:03pm
142 Views 
Post# 34469650

Sales

Just checking in.

Any sales yet?

Any Profit?

How is the GE alliance , uploading of software and selling VPT going?

I guess its still more of the relax, patience, or growing grass?

Soon will come?

Wait for VPT 4.0? Maybe 5.0? 

I hear we are relying on sneaking in the back door of a conference, and expecting GE to promote VPT?

Did I miss anything?
 

Bullboard Posts
Next >>
User Avatar Image
(1187)
•••
Post by GrahamBon Feb 28, 2022 9:03pm
142 Views 
Post# 34469650

Sales

Just checking in.

Any sales yet?

Any Profit?

How is the GE alliance , uploading of software and selling VPT going?

I guess its still more of the relax, patience, or growing grass?

Soon will come?

Wait for VPT 4.0? Maybe 5.0? 

I hear we are relying on sneaking in the back door of a conference, and expecting GE to promote VPT?

Did I miss anything?
 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities